News & Events
Why Obesity Predisposes to Severe Respiratory Failure
A hormone used to regulate insulin levels may be the key to reducing the risk of acute respiratory distress syndrome in obese patients.
Independence Blue Cross & Thomas Jefferson University Announce Innovation Collaboration
To enhance Philadelphia’s role as a global leader in health care innovation, Independence Blue Cross, and Thomas Jefferson University have announced a new partnership to boost innovation.
Population Health Signs Affiliation Agreement with Rutgers-Camden
JCPH and Rutgers University–Camden (RUC) recently signed an affiliation agreement that facilitates priority admission of RUC students to the JSPH Master of Public Health (MPH) degree program.
Jefferson Announces New Faculty Member, Michael E. Mahla, MD
Thomas Jefferson University (Jefferson) welcomed Michael E. Mahla, MD, as Professor of Anesthesiology and Director of Neuroanesthesia at the Sidney Kimmel Medical College
Practice-Changing Study Offers New Option for Tough Breast Cancer Cases
Despite advances in managing and curing some forms of breast cancer, women whose disease becomes metastatic have fewer effective options. A new phase 3 study in some of the most difficult-to-treat patients, women with endocrine-resistant disease, showed that the newly approved drug, palbociclib, more than doubled the time to cancer recurrence for women with hormone-receptor (HR+) positive metastatic breast cancer.
Karen E. Knudson, PhD to Lead the NCI-Designated Sidney Kimmel Cancer Center at Thomas Jefferson University
Dr. Knudsen is an internationally recognized researcher and highly respected leader in her field with a strong vision for future of the SKCC. Jefferson is proud to announce her new role and position.
Thomas Jefferson University & Hebrew University Faculty of Medicine Pledge Cooperation
Leading medical institutions seek to expand ties, exchange personnel and collaborate on research
Photoactive Dye Could Prevent Infection During Bone-repair Surgery
A new study demonstrates for the first time that an antimicrobial dye activated by light avidly adheres to bone to prevent bacteria from growing on bone fragments used in reconstructive surgery, and remove any bacteria that has already attached, thereby sterilizing the bone for surgery.
Jefferson & Abington Now One
Jefferson and Abington Health today announced their “hub and hub” merger has been completed, marking a new era in urban/suburban access to some of the nation’s finest clinicians, scientists, academicians and healthcare professionals.
Cytokine May Play a Major Role in Multiple Sclerosis
Jefferson researchers discover the role of a major cytokine in multiple sclerosis that could be a target for new therapy against the disease.